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Abstract
Background: In 2010 a retrospective audit was undertaken to assess the viability of using PROMs in patients with
symptomatic cardiac arrhythmias having undergone percutaneous arrhythmia ablation. A response rate of 74 %
was achieved, with finding suggesting that arrhythmia patients reported a significant impact on their work, social
and family life.
Aims: To conduct a qualitative cross sectional survey to understand patients’ perspectives of how cardiac arrhythmias
affect their daily lives, as part of a program to develop a Patient Reported Outcome Measure (PROM).
Method: Twenty five patients aged 18 or over, diagnosed with a variety of symptomatic cardiac arrhythmias referred
for a cardiac ablation procedure took part in cognitive interviews. These aimed to inform the development of a patient
reported outcome measure and to determine factors important to this patient group. Common themes were identified
using content analysis.
Results: Participants reported that symptoms of their arrhythmia caused them considerable problems and impacted
adversely on their quality of life in many ways. This extended through daily routine, work and social activities and also
to friends and family, with fear and anxiety being significant factors for most responders. Patients felt their illness was
poorly understood, even by health professionals, and often reported that they felt isolated, lacking support and
information.
Conclusion: Symptomatic cardiac arrhythmias are a source of debilitating and life limiting symptoms, having a
negative impact on quality of life. Symptoms and related complications are relevant across different arrhythmia
substrates and patient groups.
Trial registration: The study is registered on the Clinical Trials website, Identifier NCT01672528
Keywords: Cardiac arrhythmias, Patient reported outcome measures, Qualitative research, Quality of life
Introduction
Cardiac arrhythmias are a significant health problem, asso-
ciated with an increased risk of heart failure, stroke and
death [1, 2]. Estimated to affect up to 1 million people a
year in the UK they are among the top 10 reasons people
go to hospital [3, 4]. This results in a significant burden to
the NHS, and studies report that atrial fibrillation (AF)
alone is responsible for 6 % of acute medical admissions [5]
with the cost of management approximately £459 million
in 2000; equating to 1-2 % of NHS expenditure [3, 6].
Arrhythmias cause numerous symptoms including
palpitations, breathlessness, syncope and chest-pain, and
are linked to reduced quality of life, anxiety and depres-
sion [1, 7, 8]. The prevalence of many arrhythmias in-
creases with age, with AF alone occurring in up to 12 %
of elderly patients [9, 10]: As the UK population ages,
their incidence will increase, with a subsequent impact on
the NHS. While treatment primarily remains pharmaco-
logical, catheter ablation is now a common treatment
option after medicines fail, with guidelines issued by the
National Institute of Health and Care Excellence (NICE)
on its use [2, 11-14]. Studies report high success rates and
low incidence of major complications and mortality [15]
and evidence suggests that in many patients ablation may
be more beneficial than drug therapy [16, 17].
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For most patients, the aim of ablation is to reduce
symptoms and improve quality of life. In recent years it
has been recognised that patients themselves are best
placed to judge clinical benefits of medical procedures,
and the use of Patient Reported Outcome Measures
(PROMs) has been encouraged [18]. PROMs are ques-
tionnaires completed by patients before and after treat-
ment to measure any changes in their health following a
medical intervention. While there are various generic
PROMs, and numerous questionnaires aimed at patients
within specific disease groups, currently no validated
disease-specific tools exist for UK patients undergoing
catheter ablation of cardiac arrhythmias.
Background
In November 2010, a retrospective audit was undertaken
to assess the viability of using PROMs in patients with
symptomatic cardiac arrhythmias having undergone
percutaneous arrhythmia ablation. Consecutive patients
from three sites were sent: an arrhythmia specific, patient
expectation questionnaire; an adaptation of the disease
specific “Patient Perception of Arrhythmia” questionnaire;
[19] and EQ-5D-5L [20]. In total 791 patients were invited
to participate with a response rate of 74 %. Findings indi-
cated many patients quality of life prior to ablation was
severely affected by their arrhythmia, with significant im-
pacts on their work, social and family life [21]. Feed-
back from the audit was used to update and improve
the questionnaires.
As part of an iterative process to further develop and
validate the questionnaires used in the audit, a multi-
centre, prospective observational study was designed
and approved by Nottingham 1 Research Ethics Pro-
portionate Review Sub-Committee (reference 12/EM/
0164). This paper reports on Phase 1 of the study
which involved face-to-face cognitive interviews with
patients diagnosed with symptomatic cardiac arrhyth-
mias. This aimed to gain insight into factors important
to this patient group, identifying core issues of what it
is like to live with cardiac arrhythmias. As previous
authors have suggested 20 interviews are sufficient to
reach data saturation [22, 23], a sample size of 30 patients
was defined in the protocol, with fewer to be performed if
data saturation was reached earlier.
Methods
Patients were required to be aged 18+, able to communi-
cate in English or Welsh and previously diagnosed with
a symptomatic cardiac arrhythmia, awaiting and/or pre-
viously treated with catheter ablation. Purposive sampling
was used to include a relevant cross-section of patients
(i.e. comprehensive age range, different arrhythmia diag-
noses and both sexes).
Patients under the care of clinicians at University
Hospital Wales, Cardiff and Queen Elizabeth Hospital,
Birmingham were eligible. Consecutive patients who
met predefined sampling criteria were invited to par-
ticipate, and initially approached by their electrophysi-
ology physician who discussed the study and provided
written patient information. Individuals interested in
participating were subsequently contacted and where
appropriate, a mutually convenient appointment for a
face-to-face interview made. Twenty-one patients chose to
be interviewed in their homes; four opted to be inter-
viewed at a hospital site in a private room. All patients
provided written informed consent.
All interviews were conducted by one researcher
trained in cognitive interview techniques (KLW). Ses-
sions were tape-recorded with patients’ permission (one
patient declined, two were not recorded due to technical
issues), with recordings supported by field notes. Inter-
views used a semi-structured guide based on the draft
questionnaire developed by Withers et al. [21] and
modified utilising feedback from the 2010 multi-centre
audit. Using “think-aloud” techniques participants were
instructed to read the questionnaire out loud, and ver-
balise their thoughts, with the interviewer asking prob-
ing questions throughout the process. This enabled
identification of potential problems and allowed the re-
searcher to understand how questions were interpreted.
Patients were asked to discuss topics lacking clarity
within the questionnaire and suggest improvements,
they were also asked if there were issues missing from
the questionnaire they expected to see, or topics requir-
ing further investigation. At the end of the interview, pa-
tients were encouraged to discuss how their arrhythmia
affected them, and highlight difficulties in living with a
cardiac arrhythmia. Recorded interviews were transcribed
verbatim and checked for accuracy.
Interviews followed a grounded theory process of itera-
tive changes, with recurring issues used to inform and
guide subsequent interviews. Interviews were carried out
until data saturation was reached with no new issues or
concerns being identified. Qualitative content analysis with
a systematic classification process [24] was used to analyse
and code interview data. These were examined to identify
recurring themes, with modifications retested in a second
phase of interviews. Key quotations were selected to reflect
key issues. To ensure rigor, a second researcher experi-
enced in qualitative research was involved in these
processes.
Interview parameters
An initial cohort of 19 patients was interviewed from
two ablation centres (n = 13 Birmingham, n = 6 Cardiff ),
at which point data saturation was reached and revision
of the questionnaires undertaken. Following revisions,
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the questionnaire was re-tested with additional subjects
(n = 5 Cardiff, n = 1 Birmingham). Interviews took place
between October 2012 and January 2013.
Patient characteristics
Fifteen (60 %) of the 25 participants were female, and the
age range was 43 to 87 years (mean 61 years). The mean
average length of time since diagnosis, where known, was
3.24 years (range 11 months-19 years). Fourteen patients
(56 %) had received at least one ablation procedure prior
to interview, and four of these (16 %) were pending a
subsequent procedure. The remaining eleven (44 %) were
awaiting their first ablation. Primary arrhythmia diagnoses
are detailed in Table 1.
Eleven participants were retired, and 11 employed; of
these, two were on sick leave and three had reduced their
working hours due to their arrhythmia. Two participants
were not in employment and one was a full time carer.
Recorded sessions lasted between 23 and 93 minutes
(mean 50 minutes), with full sessions including study
introduction and Q&A lasting between 50 minutes and
4 hours 15 minutes.
Results
Everyday impact
All 25 patients (100 %) felt their arrhythmia affected
their life every day. This encompassed social and domes-
tic activities as well as voluntary and paid work. For
many the random nature of their symptoms prevented
them carrying out routine activities such as swimming
and dog-walking “just in case” they experienced an epi-
sode of palpitations. This had a wide ranging impact for
some: “You stop going shopping, visiting friends or even
having a conversation with your family….”. Others had
stopped going out alone as they were too worried about
what might happen if they felt unwell. These limitations
on patient activities resulted in a feeling of frustration
and helplessness, with some stating that they felt alone
as a result of their arrhythmia. “You have a complete
feeling of total isolation–you feel like you are the only
person in the world who feels like this. You no longer
have the chance to have a normal life”.
For some, arrhythmias were an issue in the workplace
with nine patients reporting problems. For these patients
this resulted in reducing working hours, rearranging
shifts or even changing jobs to try and reduce physical
or mental stress, which participants often felt was a
causative factor for triggering further episodes of palpita-
tions. “I gave up my job as it was stressful and I think
this made my arrhythmia worse”. Several patients com-
mented that they “covered up”, by attempting to hide
symptoms from colleagues, as they were concerned that
it might affect their employment. In two cases patients
had retired from work earlier than planned as they felt
unable to cope with their unpredictable and wide-
ranging symptoms. “I retired although I didn’t want to,
but going to work became too hard”.
Impact on family life
Symptoms reported by the study group were more
far-reaching than anticipated from the literature, with
responses illustrating a significant perceived impact on
family members and this placed a subsequent pressure
on some relationships. Several patients had stopped car-
ing for grandchildren with a resultant financial implica-
tion for family members. For others, reliance on friends
and family to help with tasks such as shopping left them
feeling guilty and led to a loss of independence. This
resulted in a degree of withdrawal from family contact
for those affected. “I won’t have my grandchildren on my
own anymore in case I have an episode, and my husband
will go out without me because I don’t feel up to doing
anything”. Some patients reported withholding informa-
tion about the severity and regularity of symptoms from
family members as “I don’t want to worry them even
more”. Inevitably this exacerbated their feeling of loneli-
ness and stress from strained relationships.
Fear and anxiety
Many of the patients interviewed regarded the most
important problem as being the almost constant fear
and anxiety that they reported experiencing, with 80 %
of responders describing this as an issue. Whilst some
had been told the risks associated with their condition
were small, involvement of their heart was still a sig-
nificant concern. The physical symptoms frightened
many, leading to an emotional burden they found diffi-
cult to deal with. “The fear NEVER goes away. Worry is
not a strong enough word…..I feel panic stricken ALL
the time”. Some worried their heart-rhythm problems
would damage their overall health and were afraid they
would have a heart-attack or stroke every time their
Table 1 Primary diagnoses of arrhythmia substrate
Atrial Fibrillation (AF)* Supraventricular tachycardia (SVT)** Atrial Flutter*** Ventricular Ectopics
Female, n (%) 7 (28 %) 5 (20 %) 2 (8 %) 1 (4 %)
Male, n (%) 7 (28 %) 0 3 (12 %) 0
*Two female and one male patients awaiting treatment for paroxysmal AF had already received a previous ablation for paroxysmal AF
**SVT–atrioventricular nodal re-entry tachycardia, accessory pathway, atrial tachycardia
***One female patient awaiting an ablation for persistent atrial flutter had previously received an ablation to treat persistent atrial fibrillation
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palpitation started. “The fear is worse than anything be-
cause they can come at any time. I am constantly living
in terror and frantic with fear” and “It’s like living on a
knife edge”. Some patients felt overwhelmed by their ill-
ness: “Every day I wake up worrying. It stops me leading
a normal life–I’m afraid to be on my own in case I get
an episode”.
Getting the right support and information
The level of information and support received varied
considerably, and some participants felt their primary care
physician/GP was unable to deal with their arrhythmia
and did not take their symptoms seriously. One patient re-
ported that her GP had told her “You just need a good kick
up the backside”. Several others felt that they were not be-
lieved pre-diagnosis due to the lack of obvious symptoms
and difficulties in recording the arrhythmia to get a defini-
tive diagnosis. Lack of forthcoming practical advice in the
form of background information, and how to try and rec-
ord the episodes or how to evidence and manage them left
some patients we spoke to unsure where to go for support
and advice.
Following diagnosis some participants felt they received
insufficient information about arrhythmias, adding to their
worry. Several suggested the availability of more informa-
tion would have been reassuring. “The worst thing was the
lack of information....nothing was forthcoming. During that
time anxiety levels are high because you need more
information”.
Several participants found online support groups useful,
leading to patients who had used them suggesting these
could be more widely utilised. Written information such
as patient booklets advising on symptoms, treatment and
limitations was also a resource some responders felt would
have been helpful. “The doctor told me I had AF–well that
meant nothing to me. You then get discharged with nothing
at all…….if they explained you could pick up a booklet
from your GP....,but instead you are sent back home without
knowing what to do”. In some cases lack of information
extended to the procedure and outcomes, and this was
occasionally a significant issue: “I wasn’t told that it might
not work, and definitely no mention that my symptoms
could get worse. I felt so low after the procedure because I
expected to get better but felt worse, to be honest it made
me feel like ending it all”.
Other participants felt they had received useful informa-
tion, readily supplied at the ablation clinic. This made
them more confident about what to expect with relation to
their condition and care and this reduced anxiety levels. “I
had good information from my consultant on what to
expect after my procedure which was very helpful”. Most
patients involved were unaware the procedure was not
guaranteed to work while others conceded they were
unable to remember everything they were told in clinic
appointments. This led to some participants suggesting
that written information would be helpful, as would details
for support groups. Where available, arrhythmia nurse
specialists were reported to be a helpful contact point for
information.
Successful procedure
A number of post ablation participants suggested they
had only realised the full impact of their arrhythmia fol-
lowing successful treatment having previously put some
symptoms down to aging. These patients were surprised
by their improvements following ablation. “It was a shock
to me…….I got used to being tired, and used to being
breathless. It was gone after the operation–it was a shock
when it stopped” and “I didn’t realise that’s what caused it
…… it’s not my age!” Those patients interviewed where
ablation had abolished or reduced symptoms were very
happy with the outcome and improvements it had made
to their lives: “I know that heart ablation has transformed
my life for the better and I am very grateful”. In general,
even those awaiting a further ablation were positive about




Our findings highlight some of the hurdles that patients
with cardiac arrhythmias can face in managing symp-
toms and living with uncertainty. It is important for
health professionals to appreciate the challenges these
patients face to assist them in managing their condition.
Themes identified in our data demonstrate that at least
for some patients, arrhythmias have a significant nega-
tive effect on their lives; leads to a perceived reduction
in overall quality of life; impacts all aspects of their life:
work, social, and daily activities; results in almost con-
stant fear and anxiety; and requires enormous time to
search for support and information. Walfridsson and
colleagues [25] also noted SVT patients’ decreased en-
gagement with social activities. Research has also found
patients with SVT [26] and AF [27] report feeling unin-
formed, unsupported, and distressed. Our study found
that while most participants felt supported by those
close to them, some experienced a lack of support from
the medical community, feeling they were often thought
to be “making a fuss”. Woods and colleagues [26] also
found that health-care providers were noted to minimize
patient complaints of symptoms and offered little support,
with patients feeling disbelieved when physicians ignored
their descriptions of symptoms when no tachycardia was
found on intermittent monitoring. These researchers also
reported that the patient-provider relationship suffered
when the patient perceived disbelief on the providers’ be-
half. When patients were finally correctly diagnosed it was
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seen as a relief that they were believed and could now
progress to seeking corrective treatment.
While others have also found that managing life with an
arrhythmia is formidable, our findings add new insight
into how alone some patients feel in their struggle for in-
formation and how providers may be perceived as offering
little support with symptom management, their need for
more detailed information about their condition, and
desired help with decision making regarding treatment
options. Increased emotional distress and feelings of
uncertainty related to arrhythmia have been reported
by others [26, 28]; however, our study also found that
some patient felt that their arrhythmia cause a negative
impact on family life and led to feelings of isolation,
which has been poorly described in previous literature.
Our study found 40 % of participants reported a per-
ceived negative impact on family and close friends due
to their condition, often leading to feelings of guilt and
further isolation for the patient as they felt compelled
to withdraw from some family and social occasions. For
those who no longer felt able to care for grandchildren
“just in case” they became unwell, this guilt was exacer-
bated. This was also true for those patients forced to
change jobs or retire early due to the impact of their
arrhythmia, causing a detrimental economic impact for
the family.
Strengths and limitations
While the interviews involved a range of patients, the
sample size was relatively small and it is difficult to be
sure the cohort is representative of the patient popula-
tion. Different ethnic groups and socio-economic factors
may result in patients with differing issues to those
covered in this study. Some patients invited to interview
declined, and potentially this sub-group share different
characteristics and inherent problems to those who par-
ticipated. We strengthened the study by inviting consecu-
tive patients, and by having a single researcher conducting
all interviews for consistency. Additional steps taken to
ensure quality and trustworthiness of data analysis included
the following: all transcribed interviews were checked by
the interviewer for consistency and all audio-taped inter-
views were checked line by line for accuracy. An audit
trail of definitions of data categories and coding decisions
was maintained, and a second researcher involved in data
analysis. Transferability was achieved by sampling as
diverse a group of participants as possible.
Conclusion
This study of participants’ first-hand experience of living
with cardiac arrhythmias provides useful insight into fac-
tors that are most important in the patient experience.
Although several types of arrhythmia were involved in
this study, common themes were apparent, particularly
with regard to the fear involved with living with their
condition and the concern that long-term harm would
occur. This study illustrates the unpredictability of symp-
toms is a significant burden not only to the patient, but
also to those closest to them. The unpredictable nature of
symptoms led to major lifestyle changes for patients
within the study, in the belief that aspects of their normal
routine might trigger episodes of palpitations, or even be
harmful to their heart. This had a detrimental outcome far
beyond the scope of the symptoms of the condition, lead-
ing to reduced physical activity and social interaction,
furthering the sense of isolation. Involvement of the heart,
no matter how insignificant from a clinical viewpoint is a
major concern for patients. During early consultations, it
is essential that clinicians spend time explaining the condi-
tion and its potential impact to patients to ensure they are
aware of the limitations imposed by arrhythmias. The
support of specialist arrhythmia nurses is appreciated by
patients, and use of written patient education material and
comprehensive advice and support can inform and re-
assure patients and help to provide realistic expectations
and limitations. Patient experience data is a valuable re-
source and can be used to improve the quality of health
care by identifying strengths and weaknesses of current
provision.
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